Na h-Eileanan an Iar MP Angus MacNeil has welcomed the approval of a new triple therapy treatment for cystic fibrosis patients.
Following an agreement between the Scottish Government, NHS Scotland and Vertix Pharmaceuticals, the drug Kaftrio will be made available for Cystic Fibrosis patients.
Kaftrio is a medicine that tackles the underlying causes of the disease by helping the lungs work more effectively.
Mr MacNeil said the availability of this drug was potentially transformational for cystic fibrosis patients.
He highlighted the charity The Leanne Fund which started in his constituency and offers support to those with Cystic Fibrosis and their families across the Highlands, Islands, Grampian and Tayside.
“This is extremely welcome news for those who live with Cystic Fibrosis and their families. This will benefit the majority of all CF patients and is a significant step forward. Patients in Scotland will be among the first in Europe to benefit and lead longer, healthier lives.
“The work of The Leanne Fund in my constituency and beyond is incredible and I’m sure this positive news will be warmly welcomed.”
It is estimated that around 800 people with cystic fibrosis in Scotland should be suitable for treatment with the range of medicines that are now available.